The nuclear factor κB (NF-κB) is involved in T cell activation and enhances HIV-1 gene expression. It is activated in response to numerous stimuli, including oxidative stress. Oxidative stress damages membrane lipids, proteins and nucleic acids. We have shown previously that oxidative DNA damage generated by photosensitization could trigger activation of NF-κB. We now show that a series of topoisomerase poisons (actinomycin D, camptothecin, daunomycin and etoposide) also activate NF-κB (NFKB1/RelA dimer) in ACH-2 and CEM cells. This activation is inhibited by pyrrolidine dithiocarbamate. In ACH-2 cells latently infected by HIV-1, camptothecin, daunomycin and etoposide are able to enhance virus production. Since topoisomerase poisons cause the formation of singleand double-strand breaks in DNA, these lesions might be capable of triggering NF-κB activation. Indeed, DNA damaging agents generating adducts (trans-platin and 4-nitroquinoline 1-oxide) and/or crosslinks in DNA (cis-platin and mitomycin C) do not or only weakly activate NF-κB in T cell lines.
INTRODUCTION
The transcription factor NF-κB is involved in HIV-1 gene expression and T cell activation. Its main form is a dimer of two subunits called NFKB1 (p50) and RelA (p65) (1, 2) . Activation of NF-κB is controlled by phosphorylation and proteolysis of an inhibitory subunit called IκB. In resting T cells, IκB retains the NFKB1/RelA dimer in the cytoplasm. Upon stimulation, IκB is phosphorylated by an as yet unknown kinase and then degraded by the ubiquitin-dependent activity of the 26S proteasome (3, 4) . The free NF-κB dimer then migrates to the nucleus and binds to specific sequences. Such sequences (κB elements) are found in promoter or enhancer regions of genes that are crucial for immune and acute phase responses, i.e. those coding for adhesion proteins, membrane receptors, cytokines, inducible nitric oxide synthase, etc. (reviewed in 1). The HIV-1 long terminal repeat (LTR) has two κB sequences in its enhancer region. The importance of those two sites for HIV-1 gene expression has been extensively demonstrated (5) (6) (7) .
NF-κB is activated by various agents (1), including cytokines (e.g. tumor necrosis factor, TNF), mitogens (e.g. lectins or phorbol 12-myristate 13-acetate, PMA) or UV light. The redox status of the cell modulates the activation of NF-κB and oxidative stress is itself an activator of NF-κB (8) (9) (10) (11) . Oxidative stress is defined as the exposure of cells to abnormally high concentrations of reactive oxygen species (ROS), such as superoxide anion (O 2 S-), hydrogen peroxide (H 2 O 2 ), hydroxyl radicals (OH S ), singlet oxygen ( 1 O 2 ), nitric oxide (NO S ) and hypochlorous acid (HClO). All these species can be produced in vivo (for a review see 12) . Oxidative stress causes lipid peroxidation, protein oxidation and crosslinking through disulfide bridges and DNA damage (13, 14) . Oxidative stress is detectable in HIV-infected individuals and may affect progression of the HIV-associated disease (15 and references therein).
In DNA, the main forms of damage caused by oxidative stress are single-strand breaks and oxidized bases (14) . We have previously shown that generation of oxidative DNA damage localized in DNA and consisting mainly of strand breaks and oxidation of guanines (generated with a reaction photosensitized by an intercalating agent, proflavine) was able to activate NF-κB and the replication of HIV-1 in non-productively infected lymphocytic (ACH-2) or promonocytic (U1) cells (16) .
Several chemical DNA damaging drugs activate NF-κB and/or transcription directed by the HIV-1 LTR: mitomycin C (MMC), ethyl methanesulfonate (EMS), methyl methanesulfonate (MMS), psoralen+UVA, cis-diamine dichloroplatinum (cis-Pt), 4-nitroquinoline 1-oxide (4-NQO), 5-fluorouracile and 1-β-Darabinofuranosyl cytosine (araC) (9, (17) (18) (19) (20) . UV light and ionizing radiation are inducers of NF-κB and of expression of HIV-1 genes (21, 22) and DNA damage has often been pointed to as the cause of activation, but these agents also damage other components of the cell by producing free radicals. UVC-induced NF-κB activation may not even depend on DNA damage (23) (24) (25) .
In this work we have compared the effects of drugs generating different types of DNA damage. 4-NQO, MMC, cis-Pt and trans-diamine dichloroplatinum (trans-Pt) react by addition on DNA (26, 27) , with MMC and cis-Pt also causing crosslinks (27, 28) . Actinomycin D (ActD), camptothecin (Cpt), daunomycin (Dauno) and etoposide (Etop) are topoisomerase poisons. Topoisomerases are enzymes that control the degree of supercoiling of DNA (29) . Type I topoisomerase creates transient single-strand breaks in DNA, is crucial for transcription and is *To whom correspondence should be addressed. Tel: +32 43 66 24 42; Fax: +32 43 66 24 33; Email: jpiette@ulg.ac.be Nucleic Acids Research, 1996, Vol. 24, No. 21 4243 present in the cell throughout the cell cycle, while type II topoisomerases create transient double-strand breaks and are necessary for DNA replication and cell division (29) (30) (31) . Topoisomerase poisons react with complexes formed between the enzyme and DNA and prevent religation of the strand breaks (30, 32) . Cpt traps type I topoisomerase, while Dauno and Etop are topoisomerase II poisons (30, 31, 33) . ActD is mainly known as a transcription inhibitor, but has been shown to inhibit both topoisomerases I and II (34) . In ACH-2 and CEM T lymphocytic cell lines we detected activation of NF-κB by the topoisomerase poisons but not by drugs generating adducts or crosslinks. We determined the ability of topoisomerase poisons to trigger HIV-1 reactivation from latently infected ACH-2 cells. We also studied the effects of cycloheximide, antioxidants and inhibitors of DNA polymerase and of poly(ADP-ribose) polymerase (PARP) on NF-κB activation by topoisomerase poisons.
MATERIALS AND METHODS

Chemicals
All chemicals were from Sigma (Bornem, Belgium) unless otherwise specified. Cpt, Dauno, Etop, PMA, araC and 4-NQO were dissolved in dimethylsulfoxide (DMSO) and stored at -20_C. cis-Pt and trans-Pt were dissolved in dimethylformamide and stored at 4_C. Aphidicolin and ActD were dissolved in methanol and ethanol respectively and stored at -20_C. The concentration of ActD and Dauno stocks was verified by absorbance, using ε 440 nm = 24700 for ActD and ε 480 nm = 11500 for Dauno in water, and stock solutions were protected from light. 3-Aminobenzamide (3-AB) and aclarubicin were freshly prepared in DMSO and ethanol respectively. Stock concentrations were chosen to avoid more than 0.2% solvent in culture medium. Bleomycin, cycloheximide (CHX), MMC, N-acetyl-L-cysteine (NAC; sodium form) and pyrrolidine dithiocarbamate (PDTC) were freshly prepared in water.
Cell culture and treatments
CEM and ACH-2 cells (obtained through the NIH AIDS Research and Reference Reagent Program, Bethesda, MD) were cultured in RPMI 1640 + Glutamax I + 10% fetal calf serum (Life Technologies, Gaithersburg, MD) in a 5% CO 2 atmosphere. Routinely, cells were seeded at 5 × 10 5 cells/ml. On the day preceeding the experiment, the cells were seeded at 1-1.5 × 10 6 cells/ml. For drug treatment, the cells were centrifuged and resuspended in fresh medium at a density of 10 6 cells/ml. Antioxidants or enzymes inhibitors were added if needed to the cells and incubation was prolonged for 60 (with araC, aphidicolin and 3-AB) or 120 min (with NAC and PDTC). The DNA damaging drugs were then added for the indicated times (see figure legends), then the cells were either washed twice with 1 vol serum-free medium and resuspended in complete medium or the nuclear proteins were extracted and stored at -80_C for use in gel retardation assays according to the published procedure (11) . The amounts of proteins in the samples were determined with the micro-BCA kit from Pierce (Rockford, IL).
Nuclear protein extraction and gel retardation assay
The procedure was carried out as described previously (11) . Briefly, the cells were washed in 1 ml cold phosphate-buffered saline (PBS) and centrifuged at 15 000 g for 15 s, resuspended in 200 µl cold hypotonic buffer [10 mM HEPES-KOH, 2 mM MgCl 2 , 0.1 mM EDTA, 10 mM KCl, 2 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulfonylfluoride (PMSF), 2 µg/ml aprotinin, 1 µg/ml leupeptin, 1 µg/ml pepstatin (Boehringer, Mannheim, Germany), pH 7.9], left on ice for 10 min, then vortexed and centrifuged at 15 000 g for 30 s. The pellets of nuclei were gently resuspended in 15 µl cold saline buffer (50 mM HEPES-KOH, 50 mM KCl, 300 mM NaCl, 0.1 mM EDTA, 10% v/v glycerol, 2 mM DTT, 0.5 mM PMSF, 2 µg/ml aprotinin, 1 µg/ml leupeptin, 1 µg/ml pepstatin, pH 7.9) and left for 20 min on ice. After centrifugation (15 000 g for 5 min at 4_C), aliquots of supernatant containing the nuclear proteins were taken and stored at -80_C. Gel retardation assays were performed with 32 P-labeled κB probes (Pharmacia Biotech Benelux, Roosendaal, The Netherlands), as described previously (11) . The sequences of the probes used were:
wild-type NF-κB probes
mutated NF-κB probe
The κB sites are underlined. Identical results were obtained whether the probe contained one or two κB sites. The antibodies against NFKB1 (p50), NFKB2 (p52), RelA (p65) and c-Rel used for the supershift experiments have been described elsewhere (35) and were kindly provided by Dr V. Bours.
Reverse transcriptase assay
Culture medium of control or drug-treated cells was taken 24 h after treatment and cleared by centrifugation at 15 000 g for 5 min. The reverse transcriptase (RT) assay was performed on 1 ml supernatant as described previously (11) . Virus production was calculated as the amount of radioactivity divided by the number of living cells in 1 ml culture medium (determined by Trypan blue exclusion).
RESULTS
Topoisomerase poisons activate a κB binding activity but other DNA damaging agents do not
We treated ACH-2 cells, which are T leukemic cells latently infected by HIV-1, or CEM cells, which are their uninfected counterpart, with the topoisomerase poisons ActD, Cpt, Dauno and Etop for different times at concentrations in the micromolar range. All these drugs caused the appearance of a κB binding complex ( Fig. 1A-D) . This complex could be detected at concentrations as low as 0.2 µM for Dauno and Cpt and 2-3 µM for ActD and Etop. The activation reached a maximum after 2 or 3 h treatment and was sustained for several hours with ActD and Dauno, while it decreased after a peak with Cpt and Etop. In some experiments, several bands instead of one appeared (see for instance Fig. 1C ). There was no relationship between the number of induced bands and the drug used or the number of κB sites in the probe. When only one band was detected, it had the mobility of the fastest migrating induced complex. The appearance of a κB binding complex was also observed with 10 µM amsacrine and 50 µM genistein, two other topoisomerase II poisons known to generate strand breaks in DNA (33, 36) . ACH-2 or CEM cells were also treated with 4-NQO, trans-Pt and cis-Pt. None of these drugs caused activation at concentrations of 10-100 µM (except for a slight activation observed with 4-NQO) after 5 h (Fig. 1E) or earlier (not shown); MMC did not activate NF-κB either or only moderately at concentrations >100 µM (not shown). When reported previously in the T lymphocytic cell line Jurkat JR (Wurzburg) (9), this was attributed to the prooxidant effect of this drug (37) .
To further characterize the role of DNA damage in NF-κB activation, we tested the abilities of bleomycin and aclarubicin to activate NF-κB. Bleomycin is a 'radiomimetic' drug which binds DNA and causes single-and double-strand breaks by a mechanism involving free radicals (38) . Aclarubicin is an anthracyclin drug that inhibits topoisomerases but prevents formation of the cleavable complex and does not generate DNA strand breaks (39) . Figure 2 shows that bleomycin activates NF-κB in CEM cells at concentrations causing limited toxicity (≤50% after 24 h continous treatment). Aclarubicin does not activate NF-κB even at high concentrations (up to 30 µM). This emphasizes the role of DNA strand breaks, rather than topoisomerase inhibition, in the triggering of NF-κB activation.
The identity of the induced complex was investigated by competition and supershift experiments. Figure 3 shows that the complexes induced by treatment with Etop bind specifically to the κB site, since they are competed by an excess (50-fold) of unlabeled wild-type κB probe (lane 2), but not by the same excess of mutated probe (lane 3). The two major bands were supershifted by antibodies able to recognize NFKB1 (p50) (lane 4) and an anti-RelA (p65) antiserum prevented the major part of these complexes from entering the gel (lane 6). Antibodies raised against NFKB2 (p52) (lane 5) or c-Rel (lane 7) did not react with the induced complexes. Identical results were obtained with extracts from cells treated with PMA, TNF (known to predominantly induce the NFKB1/RelA dimer), hydrogen peroxide, Cpt or Dauno (not shown). Therefore, the main band induced represents the NFKB1/RelA heterodimer. The reason for the presence of multiple bands in some experiments is unknown; the two close bands might represent differentially phosphorylated forms of NF-κB, whereas the low mobility complex might contain proteins which could not react with the antibodies tested (such as RelB).
Topoisomerase poisons trigger HIV-1 reactivation from latently infected ACH-2 cells
We then investigated whether topoisomerase poisons were able to trigger reactivation of HIV-1 in the latently infected ACH-2 cell line, since expression of HIV-1 genes is mainly under the control of NF-κB. Since continuous treatment with the drugs is toxic, the cells were treated for a limited time (2 h) and then washed twice before being reseeded in culture medium for 24 h to allow cell recovery and virus production. These treatments caused limited toxicity and allowed the cells to proliferate again after 1 or 2 days (except for treatments with ActD, which killed all the cells in <2 days even when administered at 2 µM for 30 min only). Virus production in a sample was calculated as the RT activity measured in the culture medium divided by the number of surviving cells in that sample (so as to take drug toxicity into account) and virus production in drug-treated samples was compared with virus production in control (untreated) samples. Figure 4 shows that Cpt, Dauno and Etop caused an increase in Figure 4 . HIV-1 reactivation following exposure to topoisomerase poisons. Exponentially growing ACH-2 cells were treated with: (A) 10 µM Cpt for 2 h; (B) 0.2 µM Dauno for 2 h; (C) 10 µM Etop for 2 h, then washed twice with serum-free medium and reseeded in complete medium at 10 6 cells/ml. Surviving cells were counted 24 h later using Trypan blue exclusion and the amount of virus in the medium was determined by RT assay. The RT stimulation factor was calculated as virus production (RT activity in c.p.m. divided by the number of surviving cells in 1 ml medium) in drug-treated cell samples divided by virus production in untreated cell samples (the RT stimulation factor being 1 for control samples). Data (mean ± SD) calculated from three independent experiments are shown. The percentage of surviving cells 24 h after each treatment was: (A) 45 ± 7%; (B) 84 ± 13%; (C) 63 ± 6% (mean ± SD).
virus production in drug-treated ACH-2 cells compared with control cells. Levels of reactivation observed with Cpt and Etop were comparable with those reached with H 2 O 2 (40). The highest virus production was observed with Dauno, probably because activation of NF-κB by this drug was sustained, while it was transient for Cpt and Etop (see Fig. 1 ).
Mechanism of NF-κB activation by topoisomerase poisons
To study the mechanism by which topoisomerase poisons induce NF-κB, we first used CHX, a protein synthesis inhibitor. As shown in Figure 5 , CHX had no inhibitory effect on activation by Cpt, Dauno and Etop after 3 h and even slightly enhanced NF-κB activation by these agents. Activation by ActD is presumed to require little or no protein synthesis, since this drug is a well-known transcription inhibitor. Thus, NF-κB activation by topoisomerase poisons appears independent of protein synthesis.
ROS are known to be produced following treatment by pharmacological agents that activate NF-κB (TNF, okadaic acid, anti-CD28, etc.) and antioxidants abrogate NF-κB activation by many agents (10, (41) (42) (43) (44) . We tested the effect of NAC and PDTC on NF-κB activation by PMA, H 2 O 2 , Cpt, Dauno and Etop. NAC is a precursor of glutathione and a radical scavenger, while PDTC is a radical scavenger and metal chelator (41,42 and references therein). As shown in Figure 6 and contradictory to results reported by others (10), NAC at 24 mM (and lower concentrations; not shown) was effective in CEM cells against H 2 O 2 (250 µM for 3 h) but not against PMA (100 nM for 30 min). Neither did NAC inhibit NF-κB activation by the topoisomerase poisons. In contrast, PDTC was very effective, abolishing NF-κB activation by all agents tested at 100 µM. This suggests a convergence of activation by topoisomerase poisons with pathways triggered by other agents.
Cpt causes formation of single-strand breaks by topoisomerase I, but collision between the nicked DNA-topoisomerase I complex and a DNA replication fork (or transcription machinery) leads to a double-strand break (30, 32) . Consequently, DNA polymerase inhibition prevents release of the DNA ends formed by topoisomerase II inhibition, letting the DNA ends join together via the enzyme (32). Dauno and Etop, which inhibit topoisomerase II and thus create double-strand breaks, generate single-strand breaks as well (36) . DNA single-strand breaks (generated for instance by ionizing radiation or free radicals) activate the PARP enzyme (43, 44) . We tested the effects of aphidicolin and araC, which are inhibitors of DNA polymerase (45) and of 3-AB, which inhibits PARP, to see whether these enzymes were involved in the cascade leading to NF-κB activation. Figure 7 shows that aphidicolin and araC diminish NF-κB activation by Cpt, but not by Dauno and Etop (compare lanes 5, 9 and 13 with lanes 7-8, 11-12 and 15-16) . This suggests that double-strand breaks are necessary for NF-κB activation, but that the release of DNA ends created by topoisomerase II is not. 3-AB at 3 mM did not inhibit activation by any of the three topoisomerase poisons tested (or only slightly with Dauno; compare lanes 5, 9 and 13 with lanes 6, 10 and 14), suggesting that PARP is not crucial for activation of NF-κB by topoisomerase poisons.
DISCUSSION
We have shown that topoisomerase poisons, which have in common the property of generating DNA strand breaks, are able to cause NF-κB (NFKB1/RelA dimer) activation in the T lymphocytic cell lines ACH-2 and CEM. We propose that DNA strand breaks, which are produced during oxidative stress, can lead to activation of NF-κB. DNA strand breaks are produced during exposure to H 2 O 2 or ionizing radiation (13, 14) , two agents that activate NF-κB (8, 10, 22) . We had previously shown that oxidative stress localized in the nucleus and consisting mainly of DNA strand breaks and guanine oxidation activated NF-κB in ACH-2 cells (16) . We also detected NF-κB activation following treatment of cells with bleomycin, a DNA strand break-generating drug, but not with aclarubicin, a topoisomerase inhibitor which does not stabilize cleavable complexes. Nucleic Acids Research, 1996, Vol. 24, No. 21 4247 Topoisomerase poisons activate NF-κB in the T lymphocytic cell lines ACH-2 and CEM and in the Jurkat subclone JR (data not shown), while H 2 O 2 activates NF-κB at low or moderate concentrations (100-250 µM) in these three cell lines (9, 40) . In Jurkat (lymphocytic) or U1 (promonocytic) cells, where millimolar concentrations of H 2 O 2 are required to induce NF-κB, ActD and Dauno caused activation of NF-κB, but Cpt and Etop did so only weakly (at the concentrations tested). This parallels the results of Anderson et al. (9) , who showed that NF-κB could be activated by oxidative stress in JR but not in Jurkat cells. A recent report (46) showed that Dauno triggers ceramide generation in monocytic cells. DNA damage might thus not be the only process by which Dauno triggers NF-κB and this could explain why Dauno activates NF-κB efficiently in cell lines where Cpt and Etop do not. MMC, cis-Pt, 4-NQO and araC, which had been previously shown to induce NF-κB or HIV LTR-mediated transcription in some cell types (17) (18) (19) 21) , did not activate NF-κB in our T cell lines at the concentrations tested (see Figs 1 and 7) . However, MMC, cis-Pt and 4-NQO activated NF-κB in the monocytic cell line U1 (data not shown). Thus, response to DNA damage seems to differ between cell lines and between cell types.
We show that latently HIV-infected cells produce more virions when exposed to topoisomerase poisons for a short time. Cpt was less effective than Etop and Dauno, but some authors have reported that this drug inhibits Tat-mediated transactivation of transcription from the HIV-1 LTR (47). We presume that this reactivation of the virus is mediated by NF-κB, although we did not investigate the possible involvement of other transcription factors. For example, p53 is induced by topoisomerase poisons (48, 49) and has an up-regulating effect on HIV LTR-driven transcription (50) .
Topoisomerase poisons cause strand breaks in DNA by trapping the complex formed between cut DNA and the topoisomerase enzyme. Cpt stabilizes topoisomerase I-DNA complexes once DNA is nicked, with one end (3′) linked to the enzyme through a phosphotyrosine and the other end (5′-OH) free (30) . This type of damage is repaired rapidly and efficiently when Cpt is removed (51, 52) . When topoisomerase II-DNA complexes are trapped by Etop or Dauno, there is a double-strand break where the 5′-ends are linked to the enzyme through phosphotyrosines and the 3′(-OH) ends are free. For both types of topoisomerases, the DNA ends are kept together by the enzyme until the complex is encountered by a DNA replication fork or transcription machinery. This latter event causes a double-strand break with release of the DNA ends (30) (31) (32) 53) , which often leads to cell death because it is very difficult to repair (54) . Activation of NF-κB by bleomycin and lack of activation by aclarubicin shows that DNA strand breaks are necessary and sufficient to trigger the activation process. In addition to double-strand breaks, the topoisomerase II poisons used here (amsacrine, ActD, Dauno and Etop) also cause single-strand breaks, probably because they generate free radicals (33, 36, 37) . Diminution by DNA polymerase inhibitors of NF-κB activation by topoisomerase poisons and lack of sensitivity to the PARP inhibitor 3-AB suggest, however, that the double-strand breaks mainly activate NF-κB. Moreover, Cpt and Etop at 10 µM, which lead to similar levels of NF-κB activation, have been reported to generate similar amounts of double-strand breaks, while Cpt is much more effective than Etop at creating single-strand breaks (36) .
Dauno and Etop are reduced to semiquinone radicals by various cellular enzymes (33, 37, 55 The hypothesis that NF-κB activation by topoisomerase poisons does not involve protein synthesis is reinforced by the fact that these drugs, especially ActD, inhibit transcription (30, 33, 52) . The possibility remains that transcription inhibition is the actual trigger for NF-κB activation. Disappearance of IκB following inhibition of protein synthesis is unlikely to explain activation by topoisomerase poisons, since cycloheximide did not induce NF-κB strongly under our conditions (see Fig. 4) .
We tested the ability of antioxidants to inhibit NF-κB activation following treatment with topoisomerase poisons. Under our conditions, NAC inhibited H 2 O 2 -mediated NF-κB activation and protected against H 2 O 2 toxicity, but was not effective against topoisomerase poisons or PMA. In contrast, PDTC, which is effective against all agents reported to activate NF-κB (56) , is effective against topoisomerase poisons and against H 2 O 2 , even when added at a much lower concentration (30 µM PDTC versus 250 µM H 2 O 2 ). Such discrepancies between the effects of NAC and PDTC on NF-κB have already been reported (41) and a possible explanation is that, in our system, ROS are not involved in NF-κB activation by PMA or topoisomerase poisons. Thus, PDTC would not abolish NF-κB activation by scavenging ROS but, for example, by specifically inhibiting an enzyme of the activation cascade, possibly because of its metal chelating properties. We obtained identical results with bleomycin (which causes single-and double-strand breaks) regarding the effects of CHX, NAC and PDTC (data not shown). We thus propose that DNA strand breaks trigger a signaling cascade which leads to activation of a PDTC-inhibitable enzyme (still undetermined), from which the cascade converges with other signaling pathways leading to NF-κB activation. One cannot exclude the possibility that PDTC partly prevents DNA damage by topoisomerase poisons, since Dauno and Etop (as well as amsacrine and bleomycin, but not Cpt to our knowledge) are reported to generate free radicals as a part of or in addition to their properties as DNA strand-breaking agents (33, 37) . For example, PDTC prevents the formation of DNA double-strand breaks associated with the apoptotic process triggered by Etop (57) .
The best known response pathway to DNA damage is the UV response, which activates the transcription factors AP-1, NF-κB and ATF-2 (25,58 and references therein). DNA strand breaks also trigger activation of the tumor suppressor p53 (48, 49) . Topoisomerase poisons (as well as other DNA damaging agents) and oxidative stress induce apoptosis (51, 59, 60) , probably because they cause DNA damage impossible to repair without mutation. The response to oxidative stress might be linked to the control of cell cycle/cell division that can trigger apoptosis and is directed by p53. Further studies are required to determine whether this link exists, as well as the role in NF-κB activation of oxidative stress, of proteins such as the DNA damage-dependent protein kinase and other kinases activated by DNA lesions, e.g. the product of the protooncogene c-Abl (61).
In conclusion, our results contribute to the understanding of both the mechanisms of NF-κB activation following DNA damage and the consequences of the administration of some anticancer drugs, considering the crucial role of NF-κB in immune functions.
